A man who developed bladder cancer after taking Actos has filed a lawsuit against the manufacturers of the drug. In his Actos lawsuit, Robert Bettorf alleges that the manufacturers of the drug knew that taking the prescription for more than 12 months increased the patient’s risk of developing bladder cancer, but failed to properly warn patients.
Bettorf began taking Actos for his type 2 diabetes in 2007 and was diagnosed with bladder cancer in 2008. A five-year study found that patients who took the drug for more than one year were 40% more likely to develop bladder cancer compared to other types of diabetes medication.
Health officials in France and Germany halted sales of Actos in 2011 following reports of the increased bladder cancer risk associated with the drug. The Food and Drug Administration issued additional warnings for Actos but has not announced any plans for an Actos recall.